Stimulation of erythrocyte cell membrane scrambling by nystatin

Basic and Clinical Pharmacology and Toxicology

Volumn 116, Issue 1, 2015, Pages 47-52

  Malik, Abaid ^a   Bissinger, Rosi ^a   Jilani, Kashif ^a   Lang, Florian ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; LIPOCORTIN 5; NYSTATIN; PHOSPHATIDYLSERINE; POTASSIUM ION; SODIUM ION; ANTIFUNGAL AGENT; CALCIUM; POTASSIUM; SODIUM;

ARTICLE; CALCIUM TRANSPORT; CELL DAMAGE; CELL STIMULATION; CELL VOLUME; CELLULAR PARAMETERS; CONTROLLED STUDY; ERYPTOSIS; ERYTHROCYTE MEMBRANE; EXTRACELLULAR CALCIUM; EXTRACELLULAR POTASSIUM; EXTRACELLULAR SODIUM; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PROTEIN BINDING; APOPTOSIS; CELL SIZE; CYTOLOGY; DRUG EFFECTS; ERYTHROCYTE; METABOLISM;

ANNEXIN A5; ANTIFUNGAL AGENTS; APOPTOSIS; CALCIUM; CELL SIZE; ERYTHROCYTE MEMBRANE; ERYTHROCYTES; FLOW CYTOMETRY; HUMANS; NYSTATIN; PHOSPHATIDYLSERINES; POTASSIUM; SODIUM;

EID: 84919952625     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/bcpt.12279     Document Type: Article

References (81)

1. Freedman JC, Hoffman JF. Ionic and osmotic equilibria of human red blood cells treated with nystatin. J Gen Physiol 1979;74:157-85.
2. Lye WC. Nystatin prophylaxis for fungal peritonitis: to be or not to be? Perit Dial Int 2007;27:511-3.
3. Blyth CC, Barzi F, Hale K, Isaacs D. Chemoprophylaxis of neonatal fungal infections in very low birthweight infants: efficacy and safety of fluconazole and nystatin. J Paediatr Child Health 2012;48:846-51.
4. Turner S, Williams AR, Rees JM. The use of nystatin to restore the flow properties of time-expired stored erythrocytes. Vox Sang 1987;52:182-5.
5. 2+-activated K+ channels in human erythrocyte apoptosis. Am J Physiol Cell Physiol 2003;285:C1553-60.
6. Lang E, Qadri SM, Lang F. Killing me softly - suicidal erythrocyte death. Int J Biochem Cell Biol 2012;44:1236-43.
7. Bhavsar SK, Bobbala D, Xuan NT, Foller M, Lang F. Stimulation of suicidal erythrocyte death by alpha-lipoic acid. Cell Physiol Biochem 2010;26:859-68.
8. Foller M, Huber SM, Lang F. Erythrocyte programmed cell death. IUBMB Life 2008;60:661-8.
9. Foller M, Mahmud H, Gu S, Wang K, Floride E, Kucherenko Y et al. Participation of leukotriene C(4) in the regulation of suicidal erythrocyte death. J Physiol Pharmacol 2009;60:135-43.
10. Lau IP, Chen H, Wang J, Ong HC, Leung KC, Ho HP et al. In vitro effect of CTAB- and PEG-coated gold nanorods on the induction of eryptosis/erythroptosis in human erythrocytes. Nanotoxicology 2012;6:847-56.
11. Maellaro E, Leoncini S, Moretti D, Del Bello B, Tanganelli I, De Felice C et al. Erythrocyte caspase-3 activation and oxidative imbalance in erythrocytes and in plasma of type 2 diabetic patients. Acta Diabetol 2013;50:489-95.
12. Foller M, Sopjani M, Koka S, Gu S, Mahmud H, Wang K et al. Regulation of erythrocyte survival by AMP-activated protein kinase. FASEB J 2009;23:1072-80.
13. Kucherenko Y, Zelenak C, Eberhard M, Qadri SM, Lang F. Effect of casein kinase 1alpha activator pyrvinium pamoate on erythrocyte ion channels. Cell Physiol Biochem 2012;30:407-17.
14. Zelenak C, Eberhard M, Jilani K, Qadri SM, Macek B, Lang F. Protein kinase CK1alpha regulates erythrocyte survival. Cell Physiol Biochem 2012;29:171-80.
15. Foller M, Feil S, Ghoreschi K, Koka S, Gerling A, Thunemann M et al. Anemia and splenomegaly in cGKI-deficient mice. ProcNatlAcadSciUSA 2008;105:6771-6.
16. Bhavsar SK, Gu S, Bobbala D, Lang F. Janus kinase 3 is expressed in erythrocytes, phosphorylated upon energy depletion and involved in the regulation of suicidal erythrocyte death. Cell Physiol Biochem 2011;27:547-56.
17. Klarl BA, Lang PA, Kempe DS, Niemoeller OM, Akel A, Sobiesiak M et al. Protein kinase C mediates erythrocyte "programmed cell death" following glucose depletion. Am J Physiol Cell Physiol 2006;290:C244-53.
18. Gatidis S, Zelenak C, Fajol A, Lang E, Jilani K, Michael D et al. p38 MAPK activation and function following osmotic shock of erythrocytes. Cell Physiol Biochem 2011;28:1279-86.
19. Zelenak C, Foller M, Velic A, Krug K, Qadri SM, Viollet B et al. Proteome analysis of erythrocytes lacking AMP-activated protein kinase reveals a role of PAK2 kinase in eryptosis. J Proteome Res 2011;10:1690-7.
20. Lupescu A, Shaik N, Jilani K, Zelenak C, Lang E, Pasham V et al. Enhanced erythrocyte membrane exposure of phosphatidylserine following sorafenib treatment: an in vivo and in vitro study. Cell Physiol Biochem 2012;30:876-88.
21. Shaik N, Lupescu A, Lang F. Sunitinib-sensitive suicidal erythrocyte death. Cell Physiol Biochem 2012;30:512-22.
22. Abed M, Towhid ST, Mia S, Pakladok T, Alesutan I, Borst O et al. Sphingomyelinase-induced adhesion of eryptotic erythrocytes to endothelial cells. Am J Physiol Cell Physiol 2012;303:C991-9.
23. Abed M, Towhid ST, Shaik N, Lang F. Stimulation of suicidal death of erythrocytes by rifampicin. Toxicology 2012;302:123-8.
24. Bottger E, Multhoff G, Kun JF, Esen M. Plasmodium falciparum-infected erythrocytes induce granzyme B by NK cells through expression of host-Hsp70. PLoS ONE 2012;7:e33774.
25. Firat U, Kaya S, Cim A, Buyukbayram H, Gokalp O, Dal MS et al. Increased caspase-3 immunoreactivity of erythrocytes in STZ diabetic rats. Exp Diabetes Res 2012;2012:316384.
26. Ganesan S, Chaurasiya ND, Sahu R, Walker LA, Tekwani BL. Understanding the mechanisms for metabolism-linked hemolytic toxicity of primaquine against glucose 6-phosphate dehydrogenase deficient human erythrocytes: evaluation of eryptotic pathway. Toxicology 2012;294:54-60.
27. Gao M, Cheung KL, Lau IP, Yu WS, Fung KP, Yu B et al. Polyphyllin D induces apoptosis in human erythrocytes through Ca(2)(+) rise and membrane permeabilization. Arch Toxicol 2012;86:741-52.
28. Ghashghaeinia M, Cluitmans JC, Akel A, Dreischer P, Toulany M, Koberle M et al. The impact of erythrocyte age on eryptosis. Br J Haematol 2012;157:606-14.
29. Jilani K, Lupescu A, Zbidah M, Abed M, Shaik N, Lang F. Enhanced apoptotic death of erythrocytes induced by the mycotoxin ochratoxin A. Kidney Blood Press Res 2012;36:107-18.
30. 2+ entry, ceramide formation and suicidal death of erythrocytes. Toxicol In Vitro 2013;27:52-8.
31. Kucherenko YV, Lang F. Inhibitory effect of furosemide on non-selective voltage-independent cation channels in human erythrocytes. Cell Physiol Biochem 2012;30:863-75.
32. Lang E, Qadri SM, Jilani K, Zelenak C, Lupescu A, Schleicher E et al. Carbon monoxide-sensitive apoptotic death of erythrocytes. Basic Clin Pharmacol Toxicol 2012;111:348-55.
33. Lupescu A, Jilani K, Zbidah M, Lang E, Lang F. Enhanced Ca(2+) entry, ceramide formation, and apoptotic death of erythrocytes triggered by plumbagin. J Nat Prod 2012;75:1956-61.
34. Lupescu A, Jilani K, Zbidah M, Lang F. Induction of apoptotic erythrocyte death by rotenone. Toxicology 2012;300:132-7.
35. Lupescu A, Jilani K, Zelenak C, Zbidah M, Qadri SM, Lang F. Hexavalent chromium-induced erythrocyte membrane phospholipid asymmetry. Biometals 2012;25:309-18.
36. Polak-Jonkisz D, Purzyc L. Ca influx versus efflux during eryptosis in uremic erythrocytes. Blood Purif 2012;34:209-10.
37. Qian EW, Ge DT, Kong SK. Salidroside protects human erythrocytes against hydrogen peroxide-induced apoptosis. J Nat Prod 2012;75:531-7.
38. Shaik N, Zbidah M, Lang F. Inhibition of Ca(2+) entry and suicidal erythrocyte death by naringin. Cell Physiol Biochem 2012;30:678-86.
39. Vota DM, Maltaneri RE, Wenker SD, Nesse AB, Vittori DC. Differential erythropoietin action upon cells induced to eryptosis by different agents. Cell Biochem Biophys 2013;65:145-57.
40. Weiss E, Cytlak UM, Rees DC, Osei A, Gibson JS. Deoxygenation-induced and Ca(2+) dependent phosphatidylserine externalisation in red blood cells from normal individuals and sickle cell patients. Cell Calcium 2012;51:51-6.
41. 2 increases? J CardiometabSyndr 2008;3:30-4.
42. Zbidah M, Lupescu A, Jilani K, Lang F. Stimulation of suicidal erythrocyte death by fumagillin. Basic Clin Pharmacol Toxicol 2013;112:346-51.
43. Zbidah M, Lupescu A, Shaik N, Lang F. Gossypol-induced suicidal erythrocyte death. Toxicology 2012;302:101-5.
44. Zelenak C, Pasham V, Jilani K, Tripodi PM, Rosaclerio L, Pathare G et al. Tanshinone IIA stimulates erythrocyte phosphatidylserine exposure. Cell Physiol Biochem 2012;30:282-94.
45. Abed M, Herrmann T, Alzoubi K, Pakladok T, Lang F. Tannic Acid induced suicidal erythrocyte death. Cell Physiol Biochem 2013;32:1106-16.
46. Ahmed MS, Langer H, Abed M, Voelkl J, Lang F. The uremic toxin acrolein promotes suicidal erythrocyte death. Kidney Blood Press Res 2013;37:158-67.
47. Ghashghaeinia M, Cluitmans JC, Toulany M, Saki M, Koberle M, Lang E et al. Age sensitivity of NFkappaB abundance and programmed cell death in erythrocytes induced by NFkappaB inhibitors. Cell Physiol Biochem 2013;32:801-13.
48. Abed M, Feger M, Alzoubi K, Pakladok T, Frauenfeld L, Geiger C et al. Sensitization of erythrocytes to suicidal erythrocyte death following water deprivation. Kidney Blood Press Res 2013;37:567-78.
49. Alzoubi K, Honisch S, Abed M, Lang F. Triggering of suicidal erythrocyte death by penta-O-galloyl-beta-D-glucose. Toxins (Basel) 2014;6:54-65.
50. Jilani K, Qadri SM, Lang F. Geldanamycin-induced phosphatidylserine translocation in the erythrocyte membrane. Cell Physiol Biochem 2013;32:1600-9.
51. Jilani K, Lang F. Carmustine-induced phosphatidylserine translocation in the erythrocyte membrane. Toxins (Basel) 2013;5:703-16.
52. Jilani K, Enkel S, Bissinger R, Almilaji A, Abed M, Lang F. Fluoxetine induced suicidal erythrocyte death. Toxins (Basel) 2013;5:1230-43.
53. Bissinger R, Modicano P, Frauenfeld L, Lang E, Jacobi J, Faggio C et al. Estramustine-induced suicidal erythrocyte death. Cell Physiol Biochem 2013;32:1426-36.
54. Lupescu A, Jilani K, Zbidah M, Lang F. Patulin-induced suicidal erythrocyte death. Cell Physiol Biochem 2013;32:291-9.
55. Lupescu A, Bissinger R, Jilani K, Lang F. Triggering of suicidal erythrocyte death by celecoxib. Toxins (Basel) 2013;5:1543-54.
56. Lang E, Modicano P, Arnold M, Bissinger R, Faggio C, Abed M et al. Effect of thioridazine on erythrocytes. Toxins (Basel) 2013;5:1918-31.
57. Harrison HE, Bunting H, Ordway NK, Albrink WS. The pathogenesis of the renal injury produced in the dog by hemoglobin or methemoglobin. J Exp Med 1947;86:339-56.
58. Beauvais F, Michel L, Dubertret L. Human eosinophils in culture undergo a striking and rapid shrinkage during apoptosis. Role of K+ channels. J Leukoc Biol 1995;57:851-5.
59. Benson RS, Heer S, Dive C, Watson AJ. Characterization of cell volume loss in CEM-C7A cells during dexamethasone-induced apoptosis. Am J Physiol 1996;270:C1190-203.
60. Bortner CD, Cidlowski JA. The role of apoptotic volume decrease and ionic homeostasis in the activation and repression of apoptosis. Pflugers Arch 2004;448:313-8.
61. Bortner CD, Hughes FM Jr, Cidlowski JA. A primary role for K+ and Na+ efflux in the activation of apoptosis. J Biol Chem 1997;272:32436-42.
62. Gomez-Angelats M, Bortner CD, Cidlowski JA. Protein kinase C (PKC) inhibits fas receptor-induced apoptosis through modulation of the loss of K+ and cell shrinkage. A role for PKC upstream of caspases. J Biol Chem 2000;275:19609-19.
63. Hughes FM Jr, Bortner CD, Purdy GD, Cidlowski JA. Intracellular K+ suppresses the activation of apoptosis in lymphocytes. J Biol Chem 1997;272:30567-76.
64. Hughes FM Jr, Cidlowski JA. Potassium is a critical regulator of apoptotic enzymes in vitro and in vivo. Adv Enzyme Regul 1999;39:157-71.
65. Maeno E, Ishizaki Y, Kanaseki T, Hazama A, Okada Y. Normotonic cell shrinkage because of disordered volume regulation is an early prerequisite to apoptosis. Proc Natl Acad Sci U S A 2000;97:9487-92.
66. Montague JW, Bortner CD, Hughes FM Jr, Cidlowski JA. A necessary role for reduced intracellular potassium during the DNA degradation phase of apoptosis. Steroids 1999;64:563-9.
67. Perez GI, Maravei DV, Trbovich AM, Cidlowski JA, Tilly JL, Hughes FM Jr. Identification of potassium-dependent and -independent components of the apoptotic machinery in mouse ovarian germ cells and granulosa cells. Biol Reprod 2000;63:1358-69.
68. Yurinskaya V, Goryachaya T, Guzhova I, Moshkov A, Rozanov Y, Sakuta G et al. Potassium and sodium balance in U937 cells during apoptosis with and without cell shrinkage. Cell Physiol Biochem 2005;16:155-62.
69. Yurinskaya VE, Moshkov AV, Rozanov YM, Shirokova AV, Vassilieva IO, Shumilina EV et al. Thymocyte K+, Na+ and water balance during dexamethasone- and etoposide-induced apoptosis. Cell Physiol Biochem 2005;16:15-22.
70. Isaacs D. Fungal prophylaxis in very low birth weight neonates: nystatin, fluconazole or nothing? Curr Opin Infect Dis 2008;21:246-50.
71. Mersal A, Alzahrani I, Azzouz M, Alsubhi A, Alsawaigh H, Albshri N et al. Oral nystatin versus intravenous fluconazole as neonatal antifungal prophylaxis: non-inferiority trial. J Clin Neonatol 2013;2:88-92.
72. Offner F, Krcmery V, Boogaerts M, Doyen C, Engelhard D, Ribaud P et al. Liposomal nystatin in patients with invasive aspergillosis refractory to or intolerant of amphotericin B. Antimicrob Agents Chemother 2004;48:4808-12.
73. Rosato A, Vitali C, Piarulli M, Mazzotta M, Argentieri MP, Mallamaci R. In vitro synergic efficacy of the combination of Nystatin with the essential oils of Origanum vulgare and Pelargonium graveolens against some Candida species. Phytomedicine 2009;16:972-5.
74. Borst O, Abed M, Alesutan I, Towhid ST, Qadri SM, Foller M et al. Dynamic adhesion of eryptotic erythrocytes to endothelial cells via CXCL16/SR-PSOX. Am J Physiol Cell Physiol 2012;302:C644-51.
75. Andrews DA, Low PS. Role of red blood cells in thrombosis. Curr Opin Hematol 1999;6:76-82.
76. Closse C, Dachary-Prigent J, Boisseau MR. Phosphatidylserine-related adhesion of human erythrocytes to vascular endothelium. Br J Haematol 1999;107:300-2.
77. Gallagher PG, Chang SH, Rettig MP, Neely JE, Hillery CA, Smith BD et al. Altered erythrocyte endothelial adherence and membrane phospholipid asymmetry in hereditary hydrocytosis. Blood 2003;101:4625-7.
78. Pandolfi A, Di Pietro N, Sirolli V, Giardinelli A, Di Silvestre S, Amoroso L et al. Mechanisms of uremic erythrocyte-induced adhesion of human monocytes to cultured endothelial cells. J Cell Physiol 2007;213:699-709.
79. Wood BL, Gibson DF, Tait JF. Increased erythrocyte phosphatidylserine exposure in sickle cell disease: flow-cytometric measurement and clinical associations. Blood 1996;88:1873-80.
80. Chung SM, Bae ON, Lim KM, Noh JY, Lee MY, Jung YS et al. Lysophosphatidic acid induces thrombogenic activity through phosphatidylserine exposure and procoagulant microvesicle generation in human erythrocytes. Arterioscler Thromb Vasc Biol 2007;27:414-21.
81. Zwaal RF, Comfurius P, Bevers EM. Surface exposure of phosphatidylserine in pathological cells. Cell Mol Life Sci 2005;62:971-88.